# Romark Belgium BVBA – FDA Inspection, Mar 17, 2016

Source: https://www.keypedia.com/records/fda_inspections/romark-belgium-bvba/b31ec3ae-88a2-43b2-a828-ba3f30e50630
Source feed: FDA_Inspections

> FDA inspection 969503 of Romark Belgium BVBA, March 17, 2016. Classification: No Action Indicated (NAI). 3 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 969503
- Company Name: Romark Belgium BVBA
- Inspection Date: 2016-03-17
- Classification: No Action Indicated (NAI)
- Classification Code: NAI
- Project Area: Drug Quality Assurance
- Product Type: Drugs
- Center: Human Drugs
- Office Name: Center for Drug Evaluation and Research
- Citation Count: 0

## Related Documents

- [FDA Inspection 1135007 - 2020-08-14](https://www.keypedia.com/records/fda_inspections/romark-belgium-bvba/128e6342-9a57-487a-8fd3-ca6784ba4412)
- [FDA Inspection 883655 - 2014-06-13](https://www.keypedia.com/records/fda_inspections/romark-belgium-bvba/385fd030-64a7-4fd3-aad7-de91286a3afb)
- FDA Inspection 748191 - 2011-09-15

Company: https://www.keypedia.com/companies/romark-belgium-bvba/a04db60b-b210-4c65-896a-7727782e4704

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c